S. Koshiba

In vitro evaluation of photosensitivity risk related to genetic polymorphisms of human ABC transporter ABCG2 and inhibition by drugs.

T. Ishikawa, Y. Onishi, W. Priebe, 2007, Drug metabolism and pharmacokinetics.

Disruption of N‐linked glycosylation enhances ubiquitin‐mediated proteasomal degradation of the human ATP‐binding cassette transporter ABCG2

T. Ishikawa, H. Nakagawa, A. Tamura, 2009, The FEBS journal.

Alterations in the reduced pteridine contents in the cerebrospinal fluids of LRRK2 mutation carriers and patients with Parkinson’s disease

M. Takada, H. Ichinose, S. Koshiba, 2017, Journal of Neural Transmission.

Biopterin levels in the cerebrospinal fluid of patients with PARK8 (I2020T)

H. Ichinose, S. Koshiba, K. Hasegawa, 2011, Journal of Neural Transmission.

Intramolecular Disulfide Bond Is a Critical Check Point Determining Degradative Fates of ATP-binding Cassette (ABC) Transporter ABCG2 Protein*

M. Komada, T. Ishikawa, H. Nakagawa, 2007, Journal of Biological Chemistry.

Production of cells with targeted integration of gene variants of human ABC transporter for stable and regulated expression using the Flp recombinase system.

T. Ishikawa, H. Nakagawa, A. Tamura, 2010, Methods in molecular biology.

Human ABC transporters ABCG2 (BCRP) and ABCG4

T. Ishikawa, A. Tamura, H. Saito, 2008 .

Current status and future perspective on preclinical pharmacokinetic and pharmacodynamic (PK/PD) analysis: Survey in Japan pharmaceutical manufacturers association (JPMA).

S. Koshiba, A. Goto, N. Sato, 2019, Drug metabolism and pharmacokinetics.

Human ABC transporters ABCG2 (BCRP) and ABCG4.

T. Ishikawa, A. Tamura, H. Saito, 2008, Xenobiotica; the fate of foreign compounds in biological systems.